FDA 483 - Center for Instrumental Analysis of China Pharmaceutical University - September 20, 2024

The Center for Instrumental Analysis of China Pharmaceutical University was cited for severe deficiencies in its quality system and laboratory controls. The firm lacks a quality control unit, formal training programs, and adequate procedures for managing records, computer systems, and laboratory data. These issues indicate a fundamental breakdown in ensuring drug quality.